Source: Eur Respir J 2010; 35: 118-123
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Raghu G., King T. E. Jr, Behr J., Brown K. K., du Bois R. M., Leconte I., Roux S., Swigris J.. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J 2010; 35: 118-123

Member's Comments

No comment yet.

Related content which might interest you: Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Quality of life in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 Quality of life of idiopathic pulmonary fibrosis patients Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Patients’ expectations and quality of life before introduction of pirfenidone used in idiopathic pulmonary fibrosis. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Health-related quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Prognosis symptoms, quality of life and comorbidity relationship with cough in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 Sleep quality among patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The effect of pulmonary rehabilitation on exercise tolerance pulmonary function dyspnea and quality of life in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Source: Eur Respir J 2002; 19: 209-216 Year: 2002 Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Quality of life (HQoL) and well-being in patients with idiopathic pulmonary fibrosis (IPF): the role of portable oxygen Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 Relationship between dyspnea levels and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003 Analysis of the level of dyspnea and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002 mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (4) 00084-2017; 10.1183/23120541.00084-2017 Year: 2017